Menu Search
Equities

Brainsway Ltd

BRSYF:PKC

Brainsway Ltd

Actions
  • Price (USD)2.47
  • Today's Change0.00 / 0.00%
  • Shares traded250.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Apr 11 2024 15:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.

  • Revenue in ILS (TTM)118.49m
  • Net income in ILS-15.65m
  • Incorporated2006
  • Employees134.00
  • Location
    Brainsway Ltd19 Hartum StBynet Building, Har HotzvimJERUSALEM 9777518IsraelISR
  • Phone+972 25824030
  • Fax+972 25812517
  • Websitehttps://www.brainsway.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.